The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

HVO HVIVO PLC ORD 5P



Income Statement  (£ m) 31-Dec-12 31-Dec-13 31-Dec-14 31-Dec-15 31-Dec-16
Continuing Operations
Revenue  14.40 27.49 18.47 7.72 19.85
Operating Profit/(Loss)  -0.53 -1.41 -23.05 -22.00 -22.92
Net Interest  0.01 0.00 0.00 0.02 0.02
Profit Before Tax  -0.43 -1.19 -22.71 -21.63 -22.63
Profit After Tax  0.53 1.51 -18.44 -17.91 -17.88
Discontinued Operations
Profit After Tax  0.00 0.00 0.00 0.00 0.00
PROFIT FOR THE PERIOD  0.53 1.51 -18.44 -17.91 -17.88
Attributable to:
Minority Interests  0.00 0.00 0.00 0.00 0.00
Equity Holders of Parent Company  0.53 1.51 -18.44 -17.91 -17.88
 
Continuing EPS
Earnings per Share - Basic  1.50p 3.20p -31.30p -26.00p -22.90p
Earnings per Share - Diluted  1.40p 2.90p -31.30p -26.00p -22.90p
Earnings per Share - Adjusted  1.50p 3.20p -31.30p -26.00p -22.90p
Continuing and Discontinued EPS
Earnings per Share - Basic  1.50p 3.20p -31.30p -26.00p -22.90p
Earnings per Share - Diluted  1.40p 2.90p -31.30p -26.00p -22.90p
Earnings per Share - Adjusted  1.50p 3.20p -31.30p -26.00p -22.90p
 
Dividend per Share  0.00p 0.00p 0.00p 0.00p 0.00p

Balance Sheet  (£ m) 31-Dec-12 31-Dec-13 31-Dec-14 31-Dec-15 31-Dec-16
Assets
Non-Current Assets
Property, Plant & Equipment  1.38 3.67 3.15 2.68 1.55
Intangible Assets  0.00 1.08 5.06 4.75 5.10
Investment Properties  0.00 0.00 0.00 0.00 0.00
Investments  0.00 0.00 0.00 14.25 14.15
Other Financial Assets  0.00 0.00 0.00 0.00 0.00
Other Non-Current Assets  0.00 0.00 0.00 0.00 0.00
  1.38 4.75 8.21 21.69 20.80
Current Assets
Inventories  1.61 3.12 3.73 2.14 1.99
Trade & Other Receivables  3.77 8.28 6.71 9.68 8.26
Cash at Bank & in Hand  16.34 35.81 50.83 51.24 25.68
Current Asset Investments  0.00 0.00 0.00 0.00 0.00
Other Current Assets  0.00 0.00 0.00 0.00 0.00
  21.72 47.20 61.27 63.06 35.93
 
Total Assets  23.10 51.95 69.48 84.74 56.73
 
Liabilities
Current Liabilities
Borrowings  0.00 0.00 0.00 0.00 0.00
Other Current Liabilities  -6.76 -8.36 -4.62 -17.50 -7.14
  -6.76 -8.36 -4.62 -17.50 -7.14
 
Net Current Assets  14.96 38.85 56.66 45.55 28.78
 
Non-Current Liabilities
Borrowings  0.00 0.00 0.00 0.00 0.00
Provisions  0.00 -0.11 -3.13 -3.14 -3.13
Other Non-Current Liabilities  0.00 -0.63 -0.55 -0.48 -0.40
  0.00 -0.74 -3.68 -3.62 -3.53
 
Other Liabilities  n/a n/a n/a n/a n/a
Total Liabilities  -6.76 -9.09 -8.30 -21.12 -10.67
 
Net Assets  16.34 42.86 61.18 63.62 46.05
 
Capital & Reserves
Share Capital  2.05 2.69 3.38 3.90 3.91
Share Premium Account  13.01 37.36 72.50 93.15 93.22
Other Reserves  4.42 4.44 5.37 4.55 4.65
Retained Earnings  -3.14 -1.63 -20.07 -37.98 -55.72
Shareholders Funds  16.34 42.86 61.18 63.62 46.05
 
Minority Interests/Other Equity  0.00 0.00 0.00 0.00 0.00
Total Equity  16.34 42.86 61.18 63.62 46.05

Ratios - based on IFRS 31-Dec-12 31-Dec-13 31-Dec-14 31-Dec-15 31-Dec-16
Continuing Operations
PE Ratio - Adjusted  n/a n/a n/a -8.88 -7.29
PEG - Adjusted  n/a n/a n/a n/a n/a
Earnings per Share Growth - Adjusted  n/a 113.33% n/a n/a n/a
Dividend Cover  n/a n/a n/a n/a n/a
Revenue Per Share  41.63p 57.32p 31.39p 11.19p 25.42p
Pre-Tax Profit per Share  -1.24p -2.49p -38.59p -31.37p -28.99p
Operating Margin  -3.66% -5.16% -124.85% -283.13% -78.35%
Return on Capital Employed  -2.55% -2.85% -38.31% -34.85% -51.29%
 
Continuing & Discontinued Operations
Dividend Yield  n/a n/a n/a 0.00% 0.00%
Dividend per Share Growth  n/a n/a n/a n/a n/a
Net Asset Value per Share (exc. Intangibles)  39.87p 77.76p 82.97p 75.42p 52.44p
Net Gearing  -100.01% -83.56% -83.08% -80.53% -55.76%

Data is provided by Morningstar


Market

Company Information
Updated Monthly
Company address Queen Mary BioEnterprises, Innovation Centre, 42 New Road, London, E1 2AX, United Kingdom
Company website http://www.hvivo.com
Market cap(in millions)* £ 59.00
Listing/Admission to trading 03 May 2012
Trading service SETSqx
Market AIM
Listing category -
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
27-Jul-17
FTSE index -
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Biotechnology
Country of share register GB
Segment ASQ1
MiFID Status MTF
Exchange market size 1,500
SEDOL B6ZM0X5
ISIN number GB00B6ZM0X53



HVIVO share fundamentals (HVO)